©WebNovelPub
MTL - Doctor’s Life Simulator-Chapter 365 Share Award: Appointment of Chief Scientist of Mingshi Group
"Damn, **** it!"
How did they know that Pfizer's smoking cessation drug has serious side effects, which is unscientific!
Wu Yaoming really couldn't figure out how someone would do such a large-scale trial just to verify that Pfizer's smoking cessation drug has side effects.
This requires a lot of case data, a lot of manpower and material resources, and a precise direction is needed to discover the problem of smoking cessation drugs in such a short period of time.
Looking at the author of this paper, Qin Lang, Director Qin of the New Drug Research and Development Laboratory of the First Affiliated Hospital of Zijingang University.
Wu Yaoming felt a little ridiculous and his face hurt even more.
"It turned out to be this Qin Lang again! Could it be that he is my nemesis?"
Wu Yaoming knew that he was really screwed this time. The smoking cessation drugs he pushed for had been taken off the shelves. Pfizer Pharmaceuticals and the FDA put all the dung pots on his head.
Once verified, then he will go to the prison to eat.
...
...
On the other side, Mr. Ge has been watching the share price of Ming's Pharmaceutical Group these days, waiting to see Dong Ming's joke.
As usual, today he clicked on the stock software on his mobile phone again.
Then, he saw a scene that made him somewhat unbelievable:
"This, this, how is this possible!"
Watching Mingshi Pharmaceutical Group's stock price soaring wildly, this kind of momentum should not be at all! After years of investment, Mr. Ge certainly has a keen sense of smell, so something must have happened. He immediately clicked on the relevant information, and then the whole person was stunned.
"Damn Pfizer, what the hell, this new drug can also go wrong? It can still be exposed!"
"This evil pen Wu Yaoming deserves to be imprisoned, and that Wanfeng is waiting for Lao Tzu. I lost so much money."
Thinking that the stock price of Mingshi Pharmaceutical Group will return to its peak, or even rise again, Mr. Ge is very sad.
"No, I can't spare these two bastards."
Mr. Ge was originally a person who bullied the soft and beat the hard. To be an investor, his background and social relations were also very complicated.
Before, he bowed his knees to Wu Yaoming and Wan Feng for profit, but these two people are about to fall into prison, and they have been completely thrown away by Pfizer. Of course, he doesn't mind falling into the trap.
President Ge directly called several of his younger brothers, made arrangements, and then vented his breath for him in prison.
"Ming Dong, it has to be you. Your vision, the pattern is unusual."
Mr. Ge was still somewhat convinced by Ming Dong, and this situation could be brought back.
Mr. Ge looked at the specific information, and then saw that this time Pfizer, the biggest contributor, the new drug research and development laboratory of the First Affiliated Hospital of Zijingang University, Qin Lang, Director Qin! "It turned out to be him!"
President Ge obviously never thought that it would be such a young man who they had never paid attention to in the end.
"Hey, if I had known it earlier, I would have stabilized my hand."
Mr. Ge was both regretful and envious.
In the midst of public opinion and various discussions, a new company jointly established by Qin Lang and Mingshi Pharmaceutical Group issued an announcement, a shocking news:
"On the basis of inheriting the original research and development projects of Ming's Pharmaceutical Group, the team of Qin's Pharmaceutical Company has launched a new smoking cessation drug bupropion, which has surpassed Pfizer's smoking cessation drugs in all aspects. The new drug has successfully passed the CFDA. new drug application.”
"The new drug has completed three phases of clinical trials and analyzed all data and data, and the safety and efficacy of the drug have been proven."
As soon as this heavy news came out, the entire medical circle was excited.
Moreover, another message is also scattered:
"Pfizer's smoking cessation drugs were originally obtained from the early data of Ming's Pharmaceutical Group's smoking cessation drugs. With the help of Pfizer's top R&D team, they were optimized and improved, and they started from scratch. But after all, they were stolen results from others, so there is still a lack of precipitation. and accumulation, so there are such deadly side effects."
"Pfizer's original plan was to launch the new drug first, suppress the original Ming's Pharmaceutical Group, acquire it, and justifiably engulf this new drug project, obtain their data at the complete stage, and obtain clear information at a despicable low price. The new drug research and development line and production line of the pharmaceutical group.”
"And all of this was seen through by Ming Dong of Ming's Pharmaceutical Group. For this reason, Ming Dong Ming repaired the plank road and secretly transferred the entire R&D project into Qin-style Pharmaceutical Group. He secretly researched and promoted smoking cessation drugs, and at the same time investigated and investigated Pfizer's investigations. Experiments on smoking cessation drugs, and finally, under the wise leadership of Ming Dong, not only exposed the conspiracy of Pfizer, but also successfully developed their own smoking cessation drugs."
"This smoking cessation drug has endured humiliation and has finally broken through the blockade and suppression of Pfizer in the United States, and has truly achieved a new breakthrough in the field of smoking cessation drugs in China!"
Looking at all kinds of news, the entire pharmaceutical circle is aware of it, and this Ming Dong is too tolerant and too wise.
Moreover, Ming Dong used Pfizer's Wu Yaoming to deliberately lower the stock price, purged the traitors from the management, and at the same time repurchased all their equity at a low price, which has become a classic case in business history! Ming Dong became famous! On the board of directors of Ming's Pharmaceutical Group, these staunch supporters of Ming's directors all looked at their chairman with admiration.
"Ming Dong, you are really amazing. We thought you were on the first floor, but we didn't expect you to be in the atmosphere! This wave has really suppressed Pfizer and purged all the traitors from the board of directors. ."
"Yes, what's more important is that everyone's worth has increased several times during this wave!"
After these days of public opinion fermentation, coupled with Ming's Pharmaceutical Group's forbearance and wisdom to attack the evil Pfizer, in the eyes of the public, Ming's Pharmaceutical Group is a model of national enterprises, with technology, ability, and pattern!
Therefore, the share price of Mingshi Pharmaceutical Group has long returned to its previous price, and it is only the beginning.
Shareholders, praised Ming Dong every word.
Dong Ming herself was a little confused. If she hadn't known the truth, she would have believed it.
Sure enough, someone on the board asked:
"Ming Dong, since our smoking cessation drug has been successfully developed, it will be launched soon. Is it possible to get the entire production line and R&D line back from Qin's Pharmaceutical Company?"
After all, everyone knew that this new drug would be a real cash **! Seeing the reactions of shareholders, Ming Dong also blushed a little. This new drug Mingshi Pharmaceutical Group doesn't need to think about it.
"Qin Lang, this stinky boy, I said how enthusiastically took this mess away, it turns out that everything has been planned for a long time."
Ming Dong naturally wants to understand now that Qin Lang is the real pusher behind the scenes, and the biggest beneficiary after this crisis.
However, Ming Dong knew that he deserved it all. If it weren't for what Qin Lang did, Ming's Pharmaceutical Group would have been wiped out long ago.
Therefore, Ming Dong will of course safeguard the interests of Qin Lang:
"The smoking cessation drug project is now a unique project of Qin's Pharmaceutical Company. In the future, please don't mention this matter again. In addition, I have something to announce. In recognition of this time, Qin Lang is in the Ming's Pharmaceutical Group's major Outstanding performance in the crisis, I am going to appoint Qin Lang as the chief scientist of our group's drug research and development laboratory, and at the same time give him a 1% share reward..."
Ming Dong did not explain the truth of this matter. After all, it is not a bad thing that the outside world thinks these things are her devising strategies.
Therefore, in another aspect, she is going to give Qin Lang some compensation. Of course, this is also an investment of hers, and the talent of Qin Lang is truly bound to her own ship.
Listening to the appointment and statement of Ming Dong, everyone is a little unbelievable, but in this situation, who dares to question Ming Dong, the legendary chairman?
Even Jin Yan'er was a little surprised. This Qin Lang's life was too good. This is the chief scientist of the drug research and development laboratory, and it is also a gift of 1% of the shares.
However, when thinking of the possible relationship between Qin Lang and Tang Yue, the entire board of directors understood the spirit of Dong Ming's operation.
Anyway, following Ming Dong, they will only walk on the glorious path.
Next, Wu Yaoming, the head of China at Pfizer, and Wanfeng, general manager of Zhejiang Province, were sent to prison.
The illegal construction committee of Huaguo also commended Qin Lang and his team.
In recognition of their outstanding contributions to the drug safety of Huaguo, Qin Lang's team is also recognized as the backbone of the nation in the field of Huaguo's medicine! It is a strong national enterprise.
However, following this opportunity, Qin Lang also announced the next new research and development goal on behalf of Qin's Pharmaceutical Company: the research and development of new anti-tumor drugs.
At this point, everything is developing according to Qin Lang's plan, and it has been completed. It has completely defeated Pfizer's conspiracy, launched its own smoking cessation plan, and saved Mingshi Pharmaceutical Group.
Next, as long as you wait for the new drug to be fully launched, and when you are listed on the Forbes elite list below 30, you will be able to win the Nobel Prize-level R&D project.
Qin Lang was also looking forward to it.
[Ding, congratulations to the host for leading the R&D team to launch the new drug released in China, and at the same time beat Pfizer. At the same time, it won the commendation from the Construction Committee. Get stage rewards: 1.1 life simulation points. Labyrinth IV surgery (the world's first): master class. 】
Looking at this reward, Qin Lang was also a little surprised. It turned out to be a master level, and it was the first improved technique in the world.
The so-called Cox maze IV surgery is a surgical procedure for the treatment of atrial fibrillation.
The treatment of atrial fibrillation complicated with structural heart is mainly surgery, and its development process has experienced left atrial isolation, atrioventricular node catheter ablation, corridor surgery, maze surgery, etc. Surgical treatment has made great progress, through continuous improvement, from the labyrinth type I to the current labyrinth III.
Maze III surgery has also been hailed as the "gold standard" for the treatment of atrial fibrillation.
However, due to its large trauma, complicated operation and long operation time, domestic institutions and hospitals are actually not as many as imagined, and its safety and effectiveness need to be further confirmed.
As for Qin Lang, this time he obtained a brand-new operation improved from the Labyrinth III operation, the Cox Labyrinth IV operation!
"It made a lot of money!"
It's just a phased reward, it's all so powerful, and the rewards after all are completed will be amazing.
However, Qin Lang is not in a hurry. After so many simulations, Qin Lang's mentality is very calm.
After arranging the work tasks of Wang Rou's team in Hangzhou, they are waiting for the official production of bupropion.
Qin Lang returned to the first city hospital and went back to his normal daily work.
This time, when Qin Lang came back, the doctors of the First City Hospital, of course, had a higher level of admiration and respect for Qin Lang.
Moreover, Qin Lang is now more than a surgeon. Ming's Pharmaceutical Group has announced a new appointment for Qin Lang: Chief Scientist of the Drug Research and Development Laboratory of Ming's Pharmaceutical Group!
He is also a member of the board of directors, and Qin Lang's shares are very important in the entire board of directors. Not to mention, he is now the chairman of Qin's Pharmaceutical Company, a billionaire with a 51% stake.
Therefore, in the process of being on duty now, not to mention the ordinary attending physician, the deputy chief physician, even the chief physician respects Qin Lang.
While Qin Lang was leading a case study with a resident of the Cardiology Department of the First City Hospital, Director Zhu of the Cardiology Department came in.
Director Zhu waved to Qin Lang and Dr. Sun.
"Director Qin, Dr. Sun, come here. Just now, the department sent a patient with atrial fibrillation from a lower-level hospital. Come and join us."
Director Zhu knew that Qin Lang was quite accomplished in heart-related surgery, so he planned to ask Qin Lang to give advice together.
If the patient's situation is too complicated for the team of the First City Hospital to handle, then let Qin Lang take the lead and transfer him to the First Affiliated Hospital of Zijingang University.
After all, surgery for atrial fibrillation is very difficult, and not many are carried out in the First City Hospital.
After that, let Qin Lang follow them, and observe and learn the treatment plan on the way. With Qin Lang's learning ability, I believe that after watching one, I can come back to teach.
Director Zhu has high hopes for Qin Lang.
"okay."
Qin Lang and Dr. Sun naturally got up immediately and followed Director Zhu to the ward.
Soon the three of them arrived at the hospital bed. The patient was an old aunt in her 60s, who was lying on the hospital bed with some discomfort.
Director Zhu started the inspection in person, Qin Lang watched, while Dr. Sun diligently recorded and assisted.
According to seniority, this kind of record should have come from Qin Lang, but after all, in the current Qin Lang, even Director Zhu would not dare to be arrogant.
While doing the examination, Director Zhu explained to Qin Lang and Dr. Sun:
"New atrial fibrillation is the most common clinical arrhythmia, and it increases with age. The latest research shows that the incidence of atrial fibrillation in the population is 0.4-1.0%, and there are currently about 33.5 million people worldwide. Atrial fibrillation, and with the global aging trend, the incidence of atrial fibrillation will continue to rise."
Speaking of this, Director Zhu stopped, ready to see Qin Lang's reaction. He is really unsure now, whether Qin Lang will know it or not.
In the past, it was the time when a chief director like him liked preaching and dispelling doubts and gaining the admiration and admiration of little doctors.
However, in front of Qin Lang, Director Zhu was under a lot of psychological pressure. He was afraid that Qin Lang would catch mistakes and counter-education. UU reading www.uukanshu. com
Seeing that Qin Lang listened modestly and earnestly, and listened with relish, Director Zhu was relieved.
Director Zhu continued to explain very carefully:
"Atrial fibrillation has the following clinical hazards:
1. The rapid and extremely irregular ventricular rate causes the patient to have many uncomfortable symptoms such as heart season, chest tightness, dizziness, and fatigue;
2. During atrial fibrillation, the atrium loses its systolic function, resulting in abnormal hemodynamics, resulting in different degrees of heart failure;
3. Blood stagnation in the atrium increases the risk of thrombosis and thromboembolism. Once atrial fibrillation occurs and complications such as heart failure, stroke, organ or limb arterial embolism, and severe amputation may occur, it will have a great impact on the patient's quality of life and activity tolerance, and significantly increase the patient's hospitalization rate. and medical expenses.
Therefore, early detection, clear diagnosis and active treatment of new atrial fibrillation are very necessary. "
The new revision and upgrade address of the mobile station: https://, data and bookmarks are synchronized with the computer station, no ads and fresh reading!